Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on offer for subscription

14 Aug 2020 14:36

RNS Number : 2272W
Amati AIM VCT PLC
14 August 2020
 

14 August 2020

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Update on offer for subscription

The Board of Amati AIM VCT plc (the "Company") announced on 31 October 2019 that the Company had published a prospectus in connection with proposals to raise up to £25,000,000 (with an over-allotment facility to raise up to a further £20,000,000), by way of an offer for subscription (the "Offer") of new ordinary shares (the "New Shares").

The Company announced on 29 April 2020 that £25,000,000 had been raised under the Offer and that the Board had decided not to utilise the over-allotment facility at that time. However, the Company has continued to identify and make new investments, with around £11.4 million new qualifying investments being made since the start of the Company's financial year on 1 February 2020.

Having considered the current rate of investment activity, the Board is pleased to announce that the Offer has now re-opened and the Company is seeking to raise up to £20,000,000 available under the over-allotment facility. The next allotment of New Shares under the Offer is expected to be on or around 14 September 2020 and thereafter allotments will be made at the discretion of the Board. The Offer will close at 12 noon on 16 October 2020 (unless the Offer is fully subscribed before this date and/or the Board closes the Offer earlier, which it may do in its sole discretion).

The Prospectus is available at www.amatiglobal.com and https://data.fca.org.uk/#/nsm/nationalstoragemechanism and, until 30 October 2020, copies are available for collection, free of charge, from the offices of Amati Global Investors and the offices of Dickson Minto W.S. on any Business Day. Copies can also be requested by contacting Amati Global Investors on +44 (0)131 503 9115 or by email at info@amatiglobal.com.

Subscriptions can be made online at www.amatioffer.com or by completing the subscription form contained in the Prospectus.

For further information, please contact Samantha Dalby on +44 (0)131 503 9115 or email: info@amatiglobal.com

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations ((EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPEADPLFDLEEFA
Date   Source Headline
1st Apr 20207:53 amRNSTotal Voting Rights
31st Mar 202010:11 amRNSIssue of Equity
27th Mar 20205:26 pmRNSHolding(s) in Company
27th Mar 20205:26 pmRNSHolding(s) in Company
27th Mar 20204:49 pmRNSNet Asset Value(s)
27th Mar 20209:51 amRNSTransaction in Own Shares
26th Mar 20207:37 amRNSIssue of Equity - replacement
24th Mar 202010:48 amRNSIssue of Equity
23rd Mar 202011:42 amRNSNet Asset Value(s)
20th Mar 20203:37 pmRNSHolding(s) in Company
19th Mar 20207:39 amRNSIssue of Equity - replacement
18th Mar 202012:32 pmRNSDirector/PDMR Shareholding
18th Mar 202012:29 pmRNSIssue of Equity
16th Mar 20203:15 pmRNSNet Asset Value(s)
16th Mar 202012:49 pmRNSTransaction in Own Shares
12th Mar 20204:14 pmRNSTransaction in Own Shares
12th Mar 202011:06 amRNSTransaction in Own Shares
10th Mar 20202:55 pmRNSTransaction in Own Shares
6th Mar 20203:43 pmRNSNet Asset Value(s)
6th Mar 202012:30 pmRNSTransaction in Own Shares
3rd Mar 20205:01 pmRNSDirector/PDMR Shareholding
3rd Mar 20204:17 pmRNSIssue of Equity
3rd Mar 20209:38 amRNSNet Asset Value(s)
2nd Mar 20208:30 amRNSTotal Voting Rights
25th Feb 202012:17 pmRNSTransaction in Own Shares
24th Feb 202012:06 pmRNSTransaction in Own Shares
24th Feb 202010:03 amRNSNet Asset Value(s)
21st Feb 20203:14 pmRNSTransaction in Own Shares
14th Feb 20204:37 pmRNSNet Asset Value(s)
11th Feb 20205:29 pmRNSDirector/PDMR Shareholding
11th Feb 20205:05 pmRNSReplacement Transaction in Own Shares
11th Feb 20204:53 pmRNSIssue of Equity
11th Feb 20203:40 pmRNSTransaction in Own Shares
10th Feb 20203:20 pmRNSTransaction in Own Shares
7th Feb 20204:31 pmRNSNet Asset Value(s)
7th Feb 202011:58 amRNSTransaction in Own Shares
4th Feb 20209:42 amRNSNet Asset Value(s)
3rd Feb 202012:33 pmRNSTransaction in Own Shares
3rd Feb 202010:34 amRNSTotal Voting Rights
27th Jan 20202:43 pmRNSHolding(s) in Company
24th Jan 20204:20 pmRNSNet Asset Value(s)
23rd Jan 20202:17 pmRNSTransaction in Own Shares
22nd Jan 202012:35 pmRNSTransaction in Own Shares
20th Jan 202010:12 amRNSNet Asset Value(s)
17th Jan 20203:32 pmRNSHolding(s) in Company
17th Jan 202011:56 amRNSDirector Declaration
14th Jan 20202:22 pmRNSTransaction in Own Shares
14th Jan 202010:40 amRNSIssue of Equity
10th Jan 20204:11 pmRNSNet Asset Value(s)
8th Jan 20204:13 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.